Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Head and neck squamous cell carcinoma
2020 Standout
What is polypharmacy? A systematic review of definitions
2017 Standout
Estrogen receptors and human disease
2006 Standout
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problems
2006
The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery
2003
Minimal Changes of Serum Creatinine Predict Prognosis in Patients after Cardiothoracic Surgery
2004 Standout
Oral Health and Risk of Squamous Cell Carcinoma of the Head and Neck and Esophagus: Results of Two Multicentric Case-Control Studies
2007
Benefits and risks of menopausal estrogen and/or progestin hormone use
1988
Reliability of a modified medication appropriateness index in primary care
2005
Polypharmacy and Prescribing Quality in Older People
2006
Unnecessary Drug Use in Frail Older People at Hospital Discharge
2005
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice
2006 StandoutNobel
Algunas reflexiones y consideraciones sobre el factor de impacto
2003 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity
2008 Standout
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk
1988
Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study
1989
Practical Aspects of Drug Treatment in Elderly Patients with Mobility Problems
1999
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Quality of drug prescribing in older patients: is there a problem and can we improve it?
2009
Oral Cancer and Precancerous Lesions
2002 Standout
The Beers Criteria As an Outpatient Screening Tool for Potentially Inappropriate Medications
2011
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Gynecologic consequences of long-term, unopposed estrogen replacement therapy
1988
Managing Medications in Clinically Complex Elders
2010
Reliability of a Modified Medication Appropriateness Index in Community Pharmacies
2003
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Ageing and infection
2002 Standout
The joint effect of risk factors on endometrial cancer
1988
THE USE OF PRETRANSPLANT ERYTHROPOIETIN TO NORMALIZE HEMOGLOBIN LEVELS HAS NO DELETERIOUS EFFECTS ON RENAL TRANSPLANTATION OUTCOME1
2001
Effect of a Collaborative Approach on the Quality of Prescribing for Geriatric Inpatients: A Randomized, Controlled Trial
2007
Selection of Controls in Case-Control Studies
1992
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Selection of Controls in Case-Control Studies: II. Types of Controls
1992
Suboptimal Prescribing in Older Inpatients and Outpatients
2001
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
2003 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
2014 Standout
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
1995
Frequency of medication errors in primary care patients with polypharmacy
2012
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
2003 Standout
The History and Meaning of the Journal Impact Factor
2006 Standout
Obesity in children and young people: a crisis in public health
2004 Standout
Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care
2008
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Interventions to improve the appropriate use of polypharmacy for older people
2012
Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies
1990
Reproductive factors and risk of endometrial cancer
1991
The Cost‐Effectiveness of a Clinical Pharmacist Intervention Among Elderly Outpatients
1998
Estrogen Use in Postmenopausal Women — Costs, Risks, and Benefits
1980
Predominance of Early Endometrial Cancers After Long-term Estrogen Use
1980
Involutional Osteoporosis
1986 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Measurement of health state utilities for economic appraisal
1986 Standout
Clinical consequences of polypharmacy in elderly
2013 Standout
MODIFICATION OF ANTIHYPERTENSIVE EFFECT OF &bgr;-ADRENOCEPTOR-BLOCKING AGENTS BY INHIBITION OF ENDOGENOUS PROSTAGLANDIN SYNTHESIS
1977
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
1996
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Inappropriate Prescribing
2012
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study.
1989
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Health Effects of Chronic Pesticide Exposure: Cancer and Neurotoxicity
2004 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Hormone replacement therapy and breast cancer: a qualitative review
2001
III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
2001 Standout
Responses to volume expansion and contraction in categorized hypertensive and normotensive man.
1979
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Drug-induced cancer
1981
Estrogen and Coronary Heart Disease in Women
1991 Standout
A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in Nurses
1985 Standout
Estrogen use and breast cancer interaction with body mass
1983
Tobacco Use and Oral Cancer: A Global Perspective
2001
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Estrogen Replacement Therapy: Indications and Complications
1983
A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses
1981
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
1984 Standout
The Quality of Pharmacologic Care for Vulnerable Older Patients
2004
Interventions to improve the appropriate use of polypharmacy for older people
2014
Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981.
1984
Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens
1985
Which Medical Journals Have the Greatest Impact?
1986
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Breast cancer and estrogen replacement therapy
1982
Polypharmacy in Older Adults with Cancer
2010
Definitions and characteristics of sodium sensitivity and blood pressure resistance.
1986 Standout
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of Charles C. Pulliam being referenced
Dental factors in the genesis of squamous cell carcinoma of the oral cavity
1998
Reliability of a Modified Medication Appropriateness Index in Ambulatory Older Persons
1997
The Short‐Term Effect of Interdisciplinary Medication Review on Function and Cost in Ambulatory Elderly People
2003
Reversal of Acute Renal Failure Using Hemodilution with Hydroxyethyl Starch
1983
“ALTERNATIVE” CONTROLS IN A CASE-CONTROL STUDY OF ENDOMETRIAL CANCER AND EXOGENOUS ESTROGEN
1980
Statistical and research quality of the medical and pharmacy literature
1985
Estrogen and endometrial cancer: Cases and two control groups from North Carolina
1980
Renin Profiling in Hypertension and Its Use in Treatment with Propranolol and Chlorthalidone
1976